Trials / Completed
CompletedNCT01741701
A Pilot Study of Oxaloacetate in Subjects With Treated PD
A Pilot Double-Blind, Parallel Group, Placebo Controlled Study of Oxaloacetate in Subjects With Treated Parkinson's Disease (PD)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if Oxaloacetate (OAA) is a safe and effective treatment for Parkinson's disease. Each subject will be asked to make 3 study visits and complete two safety follow-up phone calls over a 4 month period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaloacetate (OAA) | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2012-12-05
- Last updated
- 2016-03-17
- Results posted
- 2016-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01741701. Inclusion in this directory is not an endorsement.